World's Best Scientists 2026 revealed!
Fabrice Carrat

Fabrice Carrat

D-Index & Metrics

Microbiology

D-Index
84
Citations
25901
World Ranking
921
National Ranking
51

Medicine

D-Index
87
Citations
31058
World Ranking
13555
National Ranking
429

Fabrice Carrat publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Fabrice Carrat sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 387 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Fabrice Carrat D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Fabrice Carrat sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 84 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Fabrice Carrat is affiliated with Université Paris Cité in France, with a primary focus on Medicine. Their research spans several subfields including Epidemiology, Infectious Diseases, Hepatology, Clinical Psychology, and Neurology.

The main topics covered in their work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Long-Term Effects of COVID-19
  • COVID-19 epidemiological studies

Fabrice Carrat has contributed to several recent papers, including the following:

  • Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients*, 2021, British Journal of Dermatology
  • Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic, 2021, JAMA Internal Medicine
  • Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France, 2021, The Lancet Regional Health - Europe
  • Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis, 2021, Journal of Hepatology
  • Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts, 2020, Liver International

The scientist frequently publishes in venues such as:

  • Journal of Hepatology
  • Influenza and Other Respiratory Viruses
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Liver International

Fabrice Carrat has collaborated extensively with several co-authors over their career. Frequent co-authors include:

  • Mathilde Touvier
  • Marie Zins
  • Céline Dorival
  • Stanislas Pol
  • Gianluca Severi

Best Publications

  • Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies

    Fabrice Carrat;Fabrice Carrat;Elisabeta Vergu;Elisabeta Vergu;Elisabeta Vergu;Neil M. Ferguson;Magali Lemaitre;Magali Lemaitre

  • Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

    Laurent Beaugerie;Nicole Brousse;Anne Marie Bouvier;Jean Frédéric Colombel

  • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

  • Influenza vaccine: the challenge of antigenic drift.

    Fabrice Carrat;Antoine Flahault;Antoine Flahault

  • Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

    David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

    Laurent Peyrin–Biroulet;Kiarash Khosrotehrani;Fabrice Carrat;Anne–Marie Bouvier

  • Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

    Magali Lemaitre;Julien Kirchgesner;Annie Rudnichi;Fabrice Carrat

  • Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

    Julien Kirchgesner;Magali Lemaitre;Fabrice Carrat;Mahmoud Zureik

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

    Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

  • A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data.

    S. Cauchemez;F. Carrat;C. Viboud;C. Viboud;A. J. Valleron

  • The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.

    Christophe Corpechot;Fabrice Carrat;Abbas Bahr;Yves Chrétien

  • Risk factors of influenza transmission in households

    Cécile Viboud;Pierre-Yves Boëlle;Simon Cauchemez;Audrey Lavenu

  • Liver biopsy: the best, not the gold standard.

    Pierre Bedossa;Fabrice Carrat

  • The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Anne Marie Bonnand;Renée Eugénie Poupon

  • Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Armelle Poujol-Robert;Farid Gaouar

  • Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

    Laurent Beaugerie;Magali Svrcek;Philippe Seksik;Anne–Marie Bouvier

  • Further characterization of clinical and laboratory features occurring in VEXAS syndrome in a large-scale analysis of multicenter case-series of 116 French patients

    S. Georgin-Lavialle;B. Terrier;A.F. Guedon;M. Heiblig

  • Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.

    Christophe Corpechot;Farid Gaouar;Ahmed El Naggar;Astrid Kemgang

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

Frequent Co-Authors

Stanislas Pol
Stanislas Pol Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Pierre-Yves Boëlle
Pierre-Yves Boëlle Sorbonne University
Dominique Larrey
Dominique Larrey University of Montpellier
Olivier Chazouillères
Olivier Chazouillères Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées
Christophe Hézode
Christophe Hézode Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various allied health and science careers. For those interested in healthcare administration, exploring health information management job description and salary can provide insight into a growing field that combines biology knowledge with data management.

Many professionals in related healthcare roles start with a certificate or associate degree. Programs like the fastest online medical billing and coding certificate programs offer flexible pathways to quickly enter the workforce, often leading to certifications like the Certified Professional Coder (CPC). Understanding the cpc medical coding salary and career paths helps in evaluating this option.

For those aiming for more advanced roles, earning a degree from cahiim accredited health information management programs online can be crucial. These programs ensure industry standards compliance and facilitate career advancement in health data management and analysis.

Overall, combining microbiology expertise with health information and coding skills presents diverse and rewarding career opportunities in the evolving healthcare landscape.

Best Scientists Citing Fabrice Carrat

Trending Scientists

Recently Published Articles